优势供应因子120-04重组人骨成型蛋白13 peprotech细胞因子价格
- 英文名称：Recombinant Human BMP-2 (E.coli derived)
- 发布日期： 2014-12-25
- 更新日期： 2025-04-30
产品详请
| 英文名称 |
Recombinant Human BMP-2 (E.coli derived)
|
| 包装规格 |
5µg/20µg
|
| 纯度 |
%
|
| CAS编号 |
|
| 别名 |
仅供科研使用
|
| 分子式 |
|
优势供应因子120-04重组人骨成型蛋白13 peprotech细胞因子价格
120-02
Synonyms:
Bone Morphogenetic Protein-2, BMP-2A
Description:
BMPs (Bone Morphogenetic Proteins) belong to the TGF-β superfamily of structurally related signaling proteins. BMP-2 is a potent osteoinductive cytokine, capable of inducing bone and cartilage formation in association with osteoconductive carriers such as collagen and synthetic hydroxyapatite. In addition to its osteogenic activity, BMP-2 plays an important role in cardiac morphogenesis, and is expressed in a variety of tissues, including lung, spleen, brain, liver, prostate ovary and small intestine. The functional form of BMP-2 is a 26 kDa protein composed of two identical 114 amino acid polypeptide chains linked by a single disulfide bond. Each BMP-2 monomer is expressed as the C-terminal part of a precursor polypeptide, which also contains a 23 amino acid signal sequence for secretion, and a 259 amino acid propeptide. After dimerization of this precursor, the covalent bonds between the propeptide (which is also a disulfide-linked homodimer) and the mature BMP-2 ligand are cleaved by a furin-type protease. Recombinant Human BMP-2 is a 26.0 kDa homodimeric protein consisting of two 115 amino acid polypeptide chains.
北京杰辉博高生物 长期经营各种生化试剂。价格实惠，质量有保证。如需咨询相关产品请
nbsp;
优势供应因子120-04重组人骨成型蛋白13 peprotech细胞因子价格
Recombinant Human IL-19 peprotech-200-19
Recombinant Human IL-17F peprotech-200-25
Recombinant Human IL-17E peprotech-200-24
Recombinant Human IL-17D peprotech-200-27
Recombinant Human IL-17B peprotech-200-28
Recombinant Human IL-17 peprotech-200-17
Recombinant Human IL-16A（121aa） peprotech-200-16A
Recombinant Human IL-16（130aa） peprotech-200-16
Recombinant Human IL-15 peprotech-200-15
Recombinant Human IL-13 Analog peprotech-200-13A
Recombinant Human IL-13 peprotech-200-13
